Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding filovirus immunogens

Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding filovirus immunogens

US Patent 11338030 · Granted May 24, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapy for treating cancer with an intratumoral or intravenous administration o2025
Methods and compositions for inducing protective immunity against filovirus infe2024
Methods and compositions for inducing protective immunity against filovirus infe2024
Methods and compositions for inducing protective immunity against filovirus infe2024
Combination therapy for treating cancer with an antibody and intravenous adminis2023
Combination therapy for treating cancer with an antibody and intravenous adminis2023
Compositions and methods for enhancing the stability of transgenes in poxviruses2023
Recombinant modified vaccinia virus ankara (MVA) equine encephalitis virus vacci2023
Combination therapy for treating cancer with an intravenous administration of a 2022
Combination therapy for treating cancer with an intravenous administration of a 2022
Stable recombinant MVA vectors comprising modified RSV genes with reduced intram2022
Methods and compositions for inducing protective immunity against filovirus infe2021